Skip to main content

Phenylacetate and Phenylbutyrate as Novel, Nontoxic Differentiation Inducers

  • Chapter

Part of the Advances in Experimental Medicine and Biology book series (AEMB,volume 400)

Abstract

Phenylacetate, a common metabolite of phenylalanine, is a natural component of the human plasma and an endogenous growth regulator in plants (1,2). In humans, phenylacetate conjugates glutamine to yield phenylacetylglutamine (PAG), which is subsequently excreted in the urine. The latter, leading to waste nitrogen excretion, has been the basis for using sodium phenylacetate (NaPA) in treatment of hyperammonemia associated with inborn errors of urea synthesis or liver failure (3,4). Clinical experience obtained with these patients indicated that long-term treatment with high doses of NaPA (250–550 mg/kg/day) is well tolerated by both infants and adults, and effective in reducing plasma glutamine levels. These characteristics should be of value in cancer intervention considering the unique dependence of tumor cells on circulating glutamine. Preclinical studies exploring the antitumor efficacy of NaPA revealed that this simple aromatic fatty acid can selectively suppress the growth of various tumors in tissue culture and in animal models (5–7; Samid et al, unpublished). In addition to glutamine depletion in humans, phenylacetate was found to induce tumor cytostasis and differentiation through several other mechanisms (see below). Most importantly, the antitumor activity was observed with pharmacological, non-toxic drug concentrations. The demonstrated antitumor activity, easy administration (oral or IV), and lack of significant adverse effects, made phenylacetate an attractive candidate for clinical use in prevention and treatment of human neoplasms, including those which do not respond to conventional therapies. In the present report we provide a brief summary of the preclinical antitumor activity of NaPA and its derivatives.

Keywords

  • Urea Synthesis
  • Solid Tumor Cell Line
  • Endogenous Growth Regulator
  • Sodium Phenylbutyrate
  • Demonstrate Antitumor Activity

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4615-5325-0_67
  • Chapter length: 5 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   219.00
Price excludes VAT (USA)
  • ISBN: 978-1-4615-5325-0
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   279.99
Price excludes VAT (USA)
Hardcover Book
USD   379.99
Price excludes VAT (USA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sandler, M., Ruthven, C.R.J., Goodwin, B.L. Lee, A. and Stern, G.M. J. Neurol. Neurosurg. Psych. 45:366–368, 1982.

    CrossRef  CAS  Google Scholar 

  2. Wightman, F. and Lighty, D.L. Physiol. Plant. 55:17–24, 1982.

    CrossRef  CAS  Google Scholar 

  3. Brusilow, S.W., Danney, M., Waber, L.J., Batshaw, M., Burton, B., Levitsky, L., Roth, K., McKeethren, C. and Ward, J. N. Eng. J. Med. 310:1630–1634, 1984.

    CrossRef  CAS  Google Scholar 

  4. Simell, O., Sipila, L, Rajantie, J., Valle, D.L. and Brusilow, S.W. Pediatric Res. 20:1117–1121, 1986.

    CrossRef  CAS  Google Scholar 

  5. Samid D., Shack, S. and Sherman, L.T. Cancer Res. 52:1988–1992, 1992.

    PubMed  CAS  Google Scholar 

  6. Samid D., Yeh, A. and Prasanna, P. Blood 80:1576–1581, 1992

    PubMed  CAS  Google Scholar 

  7. Samid, D., Shack, S. and Myers, CE. J. Clin. Invest. 91:2288–2295, 1993.

    PubMed  CrossRef  CAS  Google Scholar 

  8. Cinatl, J. et al. 70:15-24, 1993.

    Google Scholar 

  9. Gorski G.K., McMorrow L.E. and Donaldson M.H. In Vitro Cel. Dev. Biol. 29A: 189–191, 1993.

    CrossRef  CAS  Google Scholar 

  10. Muir, R.M., Fujita, T. and Hansch, C. Plant Physiol. 42:1519–1526, 1967.

    PubMed  CrossRef  CAS  Google Scholar 

  11. Vanjusin, B.F., Bashkite, E.A., Friedrich, A. and Chvojka, L. Biochemia 1, 46:47–53, 1981.

    Google Scholar 

  12. Fibach, E., Prasanna, P., Rodgers, G.P. and Samid, D. Blood 82:2203–2209, 1993.

    PubMed  CAS  Google Scholar 

  13. Dover, G.J., Brusilow, S. and Samid, D. New Engl J Med 327:569–570, 1992

    PubMed  CAS  Google Scholar 

  14. Nebert, D.W. Nature 347:709–710, 1990.

    PubMed  CrossRef  CAS  Google Scholar 

  15. Goldstein, J.L. and Brown, M.S. Nature 343:425–430, 1990.

    PubMed  CrossRef  CAS  Google Scholar 

  16. Marshall, C.J. Science 259:1865–1866, 1993.

    PubMed  CrossRef  CAS  Google Scholar 

  17. Castillo, M. Iglesias, J., Zafra, M.F. and Garcia-Peregrin, E. Neurochem. Int. 18:171–174, 1991.

    PubMed  CrossRef  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Samid, D., Hudgins, W.R., Shack, S., Liu, L., Prasanna, P., Myers, C.E. (1997). Phenylacetate and Phenylbutyrate as Novel, Nontoxic Differentiation Inducers. In: Honn, K.V., Nigam, S., Marnett, L.J. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 2. Advances in Experimental Medicine and Biology, vol 400. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5325-0_67

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5325-0_67

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7430-5

  • Online ISBN: 978-1-4615-5325-0

  • eBook Packages: Springer Book Archive